Angel-backed Biomatters sold
Biomatters was one of Ice Angels first investments so it’s terrific to see this outcome validating the asset class.
New Zealand tech business Biomatters, a leading provider of DNA data analysis solutions worldwide, says it will be acquired by US company GraphPad.
None of the parties involved would comment on financials, but Biomatters – a darling of the business and tech press – has grown quickly to become a substantial operation.
“We have 65 staff – 47 here in NZ, 8 in the United States, and 10 in our office in Denmark,” chief executive Brett Ammundsen told the Herald this morning.
“We have around 4000 customers worldwide, ranging from individual researchers who download the software from our website, to top 10 pharmaceutical companies. Our active user-base is over 50,000 scientists.”
Biomatters has had a leg up from taxpayers at various points.
In 2010, it was one of three companies that shared $1 million growth funding through the University of Auckland Business School Entrepreneurs’ Challenge.
Crown agency NZVIF (the NZ Venture Investment Fund) invested in Biomatters, and it was also backed by business incubator IceAngels.